Michael Burry
· Cassandra Unchained
· June 15, 2026 at 19:23
· ⏱ 2 min read
| Read on Substack ↗
Summary
Michael Burry argues that Fiserv's dramatic stock decline from $226 to under $48 is largely due to a CEO departure and the unwinding of aggressive accounting from a prior regime, not a fundamental business collapse. The company's dominant market position—#1 in the IDC FinTech 100 for three years, processing 10,000 transactions per second with 1.8 billion issuer accounts—remains intact, and elevated volume may signal a bottoming process. This suggests that for investors willing to look past near-term management upheaval, the risk/reward could be asymmetric to the upside.
•Fiserv's stock has fallen from $226 to under $48 (a 10-year low) during a bull market, with eight gaps down >3% and three >10% in 18 months, including an 8% gap on the article's date.
•Ex-CEO Mike Lyons left after 13 months; the stock fell 71% during his tenure, but prior CEO's aggressive accounting and sales tricks had to be unwound, explaining the crash.
•New CEO Takis Georgakopoulos brings payments expertise from JP Morgan and Clover; the article emphasizes the business runs fine regardless of who is CEO.
•Fiserv holds the #1 spot in the 2025 IDC FinTech 100 for the third straight year, processing 10,000 transactions per second with 1.8 billion issuer accounts, 339 million deposit/loan accounts, and reaching 95% of U.S. households.
Read time2 min
Length2,403 chars
Categoryfinance
Ideas
Michael BurryFounder, Scion Asset Management; subject of The Big Short
Article provides validating data about Fiserv's business strength: #1 IDC FinTech 100 for three years, 10,000 tps, 1.8B issuer accounts, 339M deposit/loan accounts, 95% U.S. household reach. Author im
Article provides validating data about Fiserv's business strength: #1 IDC FinTech 100 for three years, 10,000 tps, 1.8B issuer accounts, 339M deposit/loan accounts, 95% U.S. household reach. Author implies the stock's decline is overdone and elevated volume may indicate bottoming, suggesting potential upside for patient investors.
Risk: CEO change after only 13 months is a thesis violation; new CEO's execution is unproven, and the stock could continue to decline if investors remain skeptical.